For an older adult considering narrative exposure therapy for PTSD in Massachusetts, NET combines life-story context with clinician-guided imaginal exposure to successive traumatic memories. That means working with memories in imagination, not simply talking about your past. One small older-adult trial supports considering NET, but does not establish superiority over present-centered therapy or improvement in resilience.
Understanding narrative exposure therapy for PTSD in Massachusetts
NET combines reconstruction of autobiographical memory with cognitive-behavioral exposure in a short-term, trauma-focused intervention. It places traumatic experiences within the broader story of your life. The method allows imaginal exposure to multiple traumatic memories, addressing successive events in a controlled way to support gradually becoming less reactive to painful memories.
How present-centered therapy differs
In the same study, present-centered therapy (PCT) used problem-solving focused on current stressors and difficulties in interpersonal communication, rather than traumatic memories. Both approaches were active treatments.
- NET: directs attention toward traumatic memories within a lifespan perspective.
- PCT: directs attention toward present-day problems and interpersonal communication.
For you, the meaningful distinction is the focus of professional care: working directly with trauma memories or addressing current difficulties without that focus.
What the older-adult trial found
Two publications report one randomized trial, not independent replications. It enrolled 33 outpatients aged 55 to 81 with PTSD at two Dutch treatment facilities. Participants received 11 sessions of NET or PCT. The small sample limits how confidently these findings extend to other older adults, including those in Massachusetts.
The average participant was in their early sixties. People with severe cognitive impairment, current high suicide risk, active psychotic or bipolar disorder, or current substance dependence were excluded. These findings therefore cannot establish suitability across all older-adult clinical situations.
The primary trial report found a medium post-treatment difference in clinician-rated PTSD scores favoring PCT, but no statistically significant difference at follow-up. The secondary analysis of symptoms and resilience found no significant between-group effects after treatment or at mean follow-up.
Separating symptom change from resilience
A symptom reduction is not the same as improved quality of life or confidence in managing challenges. The secondary analysis measured both kinds of outcomes:
| Outcome | Trial finding | Interpretation |
|---|---|---|
| Self-reported PTSD, depression, general psychopathology | Improved within NET group at follow-up | Does not establish superiority |
| Self-efficacy and quality of life | No significant change in either group | Resilience gains were not demonstrated |
| Personal-growth cognitions | No significant change in either group | Symptom relief did not establish growth |
- Within-group change compares a treatment group with its own earlier scores.
- Between-group comparisons test differences between the treatments.
- A non-significant difference does not prove that treatments are equivalent.
Choosing care with your preferences in mind
Your comfort with directly addressing traumatic memories matters in a treatment discussion. NIMH explains that treatment planning should reflect individual needs and medical circumstances under a mental health professional’s guidance. In this trial, participants and therapists set session frequency together, taking preferences and practical possibilities into account.
NIMH identifies symptom relief, daily functioning, and quality of life as separate goals of psychotherapy. Your priorities can therefore extend beyond whether a PTSD symptom score falls.
A therapy method is different from a care setting. NET describes how treatment works, not which program you need. When considering mental health treatment in Massachusetts, distinguish the setting and support available from the particular therapy a clinician uses.
NET availability at MVBH is not confirmed. To discuss care options, call 978-233-9597. A conversation does not guarantee a particular method or admission.
Reviewed by clinical staff
Frequently Asked Questions
Is NET ordinary storytelling?
No. NET is structured trauma-focused treatment, not simply an opportunity to tell your history. It combines autobiographical context with clinician-guided imaginal exposure to traumatic memories. The life perspective helps place experiences in context, while the exposure component directly addresses memories of successive traumatic events.
How does its focus differ from present-centered therapy?
NET focuses on traumatic memories within the context of a person’s life. In the trial, present-centered therapy used problem-solving around current stressors and difficulties in interpersonal communication instead of focusing on trauma memories. Both were active treatments, with different emphases rather than interchangeable processes.
Was it studied in older adults?
Yes. A small randomized trial in the Netherlands studied 33 outpatients aged 55 to 81 with PTSD. Participants were assigned to 11 sessions of NET or present-centered therapy. The two publications report different analyses from that same trial, not two separate studies confirming the findings.
Does this research show NET is better?
No. The primary report found a post-treatment PTSD score difference favoring present-centered therapy, but no significant difference at follow-up. The secondary analysis did not find significant between-group differences. Improvements within the NET group do not establish superiority, and resilience measures did not significantly improve in either group.